Nexalin Technology Stock Return On Equity
| NXLIW Stock | USD 0.56 0.01 1.82% |
Nexalin Technology fundamentals help investors to digest information that contributes to Nexalin Technology's financial success or failures. It also enables traders to predict the movement of Nexalin Stock. The fundamental analysis module provides a way to measure Nexalin Technology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nexalin Technology stock.
| Last Reported | Projected for Next Year | ||
| Return On Equity | (1.45) | (1.38) |
Nexalin | Return On Equity |
Nexalin Technology Company Return On Equity Analysis
Nexalin Technology's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Nexalin Technology Return On Equity | -2.02 |
Most of Nexalin Technology's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nexalin Technology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Nexalin Return On Equity Driver Correlations
Understanding the fundamental principles of building solid financial models for Nexalin Technology is extremely important. It helps to project a fair market value of Nexalin Stock properly, considering its historical fundamentals such as Return On Equity. Since Nexalin Technology's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Nexalin Technology's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Nexalin Technology's interrelated accounts and indicators.
Click cells to compare fundamentals
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Nexalin Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Nexalin Technology has a Return On Equity of -2.0223. This is 91.56% lower than that of the Health Care Equipment & Supplies sector and 76.84% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Nexalin Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nexalin Technology's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nexalin Technology could also be used in its relative valuation, which is a method of valuing Nexalin Technology by comparing valuation metrics of similar companies.Nexalin Technology is currently under evaluation in return on equity category among its peers.
Nexalin Fundamentals
| Return On Equity | -2.02 | ||||
| Return On Asset | -1.19 | ||||
| Operating Margin | (48.32) % | ||||
| Number Of Shares Shorted | 1.5 K | ||||
| Revenue | 110.75 K | ||||
| EBITDA | (5.69 M) | ||||
| Net Income | (4.65 M) | ||||
| Total Debt | 4.46 K | ||||
| Book Value Per Share | 0.43 X | ||||
| Cash Flow From Operations | (3.84 M) | ||||
| Beta | 3.57 | ||||
| Total Asset | 3.63 M | ||||
| Retained Earnings | (77.04 M) | ||||
| Working Capital | 3 M | ||||
| Net Asset | 3.63 M |
About Nexalin Technology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nexalin Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nexalin Technology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nexalin Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Nexalin Stock Analysis
When running Nexalin Technology's price analysis, check to measure Nexalin Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nexalin Technology is operating at the current time. Most of Nexalin Technology's value examination focuses on studying past and present price action to predict the probability of Nexalin Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nexalin Technology's price. Additionally, you may evaluate how the addition of Nexalin Technology to your portfolios can decrease your overall portfolio volatility.